Harmony Biosciences Holdings (HRMY)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Revenue (ttm)	US$ in thousands	710,199	672,548	630,000	585,184	548,499	507,747	476,532	451,378	419,060	383,158	319,980	290,957	268,890	236,824	233,336
Total assets	US$ in thousands	999,200	928,135	858,383	846,985	811,448	777,766	760,183	715,092	673,870	643,464	505,034	464,005	433,443	391,092	359,695
Total asset turnover		0.71	0.72	0.73	0.69	0.68	0.65	0.63	0.63	0.62	0.60	0.63	0.63	0.62	0.61	0.65

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $710,199K ÷ $999,200K
= 0.71

The total asset turnover of Harmony Biosciences Holdings has shown a fluctuating trend over the periods provided in the data. Starting at 0.65 on June 30, 2021, it decreased to 0.61 by September 30, 2021, before slightly increasing to 0.62 by December 31, 2021. Thereafter, the ratio remained relatively stable around 0.62 to 0.63 until June 30, 2022.

From September 30, 2022, to September 30, 2023, there was a gradual decline in the total asset turnover, dropping to 0.60 by September 30, 2022, before recovering slightly to 0.65 by September 30, 2023. Subsequently, the ratio showed an improving trend, increasing to 0.68 by December 31, 2023, and further to 0.69 by March 31, 2024.

The total asset turnover continued to rise steadily, reaching 0.73 by June 30, 2024, and then slightly decreasing to 0.72 by September 30, 2024. Over the overall period, the company's ability to generate sales from its total assets has exhibited variability but showed signs of improvement in the later periods, indicating possible operational efficiency enhancements.